How to Avoid Counterfeit Medical Equipment When Procuring for Your Hospital
How to Avoid Counterfeit Medical Equipment When Procuring for Your Hospital
Counterfeit and substandard medical equipment is a growing concern for hospitals across India. From fake surgical gloves that tear under pressure to diagnostic devices that return inaccurate readings, the consequences of procuring from unverified sources can range from operational disruption to genuine patient harm.
For hospital procurement officers, the pressure to find cost-effective equipment is real — but the risks of prioritising price over verification are significant. This guide outlines the key warning signs of counterfeit medical equipment and practical steps your procurement team can take to source safely.
Why Counterfeit Medical Equipment Is a Growing Problem in India
India's medical equipment market is large, fragmented, and growing rapidly. With thousands of manufacturers, distributors, and resellers operating across the country, it can be difficult for procurement teams to distinguish between verified suppliers and those offering substandard or counterfeit products.
The challenge is compounded by the fact that counterfeit equipment often looks identical to genuine products. Packaging, labelling, and even certification documents can be replicated. Without a structured verification process, procurement teams may unknowingly introduce unsafe equipment into clinical environments.
Government agencies including the Central Drugs Standard Control Organisation (CDSCO) have taken steps to regulate medical devices in India — but enforcement remains uneven, particularly for equipment sourced through informal channels or unverified distributors.
Warning Signs of Counterfeit or Substandard Medical Equipment
Procurement teams should be alert to the following warning signs when evaluating suppliers:
Unusually low pricing is one of the most common indicators. Genuine medical equipment manufactured to regulatory standards carries real costs — materials, testing, certification, and quality control. A quotation that is significantly below market rate should prompt further verification rather than immediate acceptance.
Missing or unverifiable certifications are another red flag. Legitimate manufacturers will readily provide CDSCO registration certificates, ISO certification documents, and test reports. If a supplier is unable or unwilling to provide these documents, or if the documents cannot be verified through official channels, this is a serious concern.
Unfamiliar or unregistered manufacturers should also prompt caution. Before placing an order, procurement teams should verify that the manufacturer is registered with CDSCO and that the specific product is listed under their registration. The CDSCO online portal allows hospitals to search for registered medical devices and their manufacturers.
How to Verify a Medical Equipment Manufacturer in India
A structured verification process significantly reduces the risk of procuring counterfeit or substandard equipment. Here are the key steps:
Check CDSCO registration. Visit the CDSCO website and search for the manufacturer and product. Medical devices in India are classified under Class A, B, C, and D — higher risk devices require more stringent registration. Verify that the manufacturer holds a valid licence for the specific product category.
Request ISO certification documents. ISO 13485 is the international standard for quality management systems in medical device manufacturing. Ask suppliers to provide their current ISO certificate and verify the certification body and expiry date.
Ask for product test reports. Reputable manufacturers maintain test reports for their products. Request copies and check that testing was conducted by an accredited laboratory.
Evaluate the supplier's track record. Ask for references from hospitals or healthcare institutions the supplier has previously served. A verified supplier with an established track record in healthcare procurement is significantly lower risk than an unknown vendor.
The Risk of Sourcing Through Unverified Distributors
Many hospitals in India procure equipment through distributors rather than directly from manufacturers. While reputable distributors play a legitimate role in the supply chain, the distributor model also introduces additional layers of risk.
Unverified distributors may source products from multiple manufacturers — not all of whom meet regulatory standards. They may also repackage or relabel products in ways that obscure the original manufacturer. Without visibility into the manufacturing source, hospitals have limited ability to verify product authenticity.
Where possible, procurement teams should seek to understand the manufacturing source of the equipment they are procuring, and verify that source independently.
How a Verified Procurement Network Reduces Risk
One of the most effective ways to reduce counterfeit risk in hospital procurement is to source through a partner that has already completed manufacturer verification on your behalf.
A verified procurement network maintains ongoing relationships with manufacturers who have been assessed against regulatory and quality benchmarks — including CDSCO registration, ISO certification, and supply track record. When hospitals source through such a network, they benefit from the verification work already completed, rather than conducting it independently for every procurement requirement.
This approach is particularly valuable for procurement teams managing multiple equipment categories simultaneously, where the time and resource required for individual manufacturer verification can be significant.
Conclusion
Counterfeit medical equipment is a genuine risk in India's healthcare procurement landscape — but it is a manageable one. With a structured verification process, awareness of warning signs, and access to reliable sourcing partners, hospital procurement teams can significantly reduce their exposure to substandard products.
The investment in proper verification is always worth making. The cost of procuring counterfeit equipment — in patient safety, regulatory risk, and operational disruption — far exceeds any short-term saving on price.
